Parkwood LLC Astrazeneca PLC Transaction History
Parkwood LLC
- $1.42 Billion
- Q3 2024
A detailed history of Parkwood LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parkwood LLC holds 72,685 shares of AZN stock, worth $4.82 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
72,685
Previous 58,040
25.23%
Holding current value
$4.82 Million
Previous $4.53 Million
25.09%
% of portfolio
0.4%
Previous 0.56%
Shares
23 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...